Navigation Links
Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group
Date:6/10/2009

WALTHAM, Mass., June 10 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that despite the economic downturn, market growth in the European gastrointestinal (GI) videoscope segment will be fueled by increased colorectal cancer (CRC) screening programs in France, Germany, and the UK. As detailed in the recently released European Markets for GI Endoscopy Devices 2009 report, the rise in screening initiatives will expand patient awareness of the disease and, accordingly, grow GI videoscope procedure volumes through 2013.

Several CRC and celiac disease screening programs are now in place throughout Europe, heightening patient awareness of the importance of screening and improving access to the associated procedures. France, Germany, and the UK each have nationwide CRC screening initiatives, while regional initiatives exist in Italy and Spain. Screening programs will continue to expand in Europe over the next 5 years, in spite of the economic crisis, prompting a rise in colonoscopy and esophagogastroduodenoscopy (EGD) procedure volumes. Because GI videoscopes are used in these procedures, the expansion of the screening programs will fuel demand for GI videoscopes.

"The number of GI endoscopy procedures performed in Europe will experience considerable growth through 2013 due to increasing patient and physician demand for minimally invasive procedures," says Tiffanie Demone, Senior Analyst at MRG. "Minimally invasive procedures allow for rapid patient recovery and short, if any, hospital stays. These procedures thus have several advantages over open surgical procedures, including cost savings for health care systems and improved quality of life for patients."

MRG's European Markets for Gastrointestinal (GI) Endoscopy Devices 2009 now includes more competitor coverage and country-specific insights than ever before. The report provides detailed analysis of key industry competitors, procedural trending, and revenue growth for the major GI endoscopy devices in France, Germany, Italy, the UK, and Spain. For the first time, this report includes a market analysis of enteral feeding giving sets, GI cytology brushes, and biliary cytology brushes. Additionally, the 2009 report includes analysis of all segments of the Spanish GI endoscopy device market.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves New Roche West Nile Virus Blood Screening Test
2. New lung cancer guidelines oppose general CT screening
3. New Lung Cancer Guidelines Oppose General CT Screening
4. Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
5. Screening Proposed for Childhood Cholesterol Levels
6. A new technology for cancer screening listens for the signs of cancer
7. Study Questions Genetic Screening for Treatable Diseases
8. Cervical cancer screening: Too many are left unprotected
9. Simple, personalized interventions improve colorectal cancer screening rates
10. Doctors Office Outreach Boosts Colon Cancer Screening
11. Jefferson researchers find personalized interventions key to improving colon cancer screening rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... Medical Director of its Sienna Plantation facility. , “We are pleased to announce ... said Dr. Michael (Derek) Caraway, Area Medical Director of First Choice Emergency Room – ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... pain afflicting 8 of 10 Americans at some point in their lives, some of us ... equally vexing condition stems from a variety of causes that can be effectively targeted by ... president of Atlantic Spine Center. , Nestled between your neck and lower back, the ...
(Date:8/16/2017)... ... , ... “Faith, Through The Eyes of A Child” is the creation of published author, Pauline ... down at her. Since she was in such great pain, my mother thought that her ... went well. It wasn’t until I was about eight years old, when I had a ...
(Date:8/15/2017)... California (PRWEB) , ... August 15, 2017 , ... ... definitions of disease. It’s reaching out to a patient who feels isolated. It’s ... art amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)...   Second-quarter 2017 revenues of ... share from continuing operations ... to $110 million Second-quarter ... million Second-quarter 2017 adjusted ... 8 percent to $0.93 ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and ... driving up healthcare costs and threatening outcomes, were problems ... supply and IVD industry that support them, met this ... market researcher said that drugs of abuse, procalcitonin and ... sessions at the organization,s 69th meeting in ...
Breaking Medicine Technology: